# Xenetic Biosciences Posts $0.72 GAAP Loss Per Share as Revenue Falls 29.4%

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/56892
Published: 2026-11-13T16:48:31.000Z
Updated: 2026-11-13T16:48:31.000Z
Section: Business

> Revenue totaled $0.7 million in the third quarter of 2026.

Xenetic Biosciences, Inc. (XBIO) recorded a GAAP net loss per share of $0.72 for the third quarter of 2026 as revenue declined 29.4% year over year to $0.7 million.